VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q3 2017. The put-call ratio across all filers is 1.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $2 | -99.8% | 57 | +1.8% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 56 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $2,000 | 0.0% | 56 | -1.8% | 0.00% | 0.0% |
Q1 2022 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,000 | 0.0% | 57 | +1.8% | 0.00% | 0.0% |
Q3 2021 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,000 | 0.0% | 56 | -44.6% | 0.00% | 0.0% |
Q1 2018 | $2,000 | 0.0% | 101 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $2,000 | 0.0% | 101 | +1.0% | 0.00% | 0.0% |
Q3 2017 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,000 | -98.0% | 100 | -97.7% | 0.00% | -98.4% |
Q1 2017 | $98,000 | +3.2% | 4,279 | -5.8% | 0.06% | -4.6% |
Q4 2016 | $95,000 | -78.7% | 4,542 | -73.2% | 0.06% | -82.1% |
Q3 2016 | $447,000 | – | 16,927 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |